Sibling Death in Childhood, Young Adulthood Linked to Risk for CVD
By Elana Gotkine HealthDay Reporter
MONDAY, Jan. 8, 2024 -- Sibling death in childhood and early adulthood is associated with an increased risk for cardiovascular disease (CVD), according to a study published online Jan. 8 in JAMA Network Open.
Chen Huang, from the School of Public Health at Fudan University in Shanghai, and colleagues examined the association between sibling death in the early decades of life and subsequent risk for incident early-onset CVD in a population-based cohort study composed of 2,098,659 individuals born in Denmark from 1978 to 2018.
The researchers found that 1,286 and 76,862 individuals in the bereaved and nonbereaved groups, respectively, were diagnosed with CVD during the median follow-up of 17.52 years. Sibling death in childhood and early adulthood was associated with an increased risk for overall CVD (cumulative incidence in bereaved and nonbereaved individuals at age 41 years: 1.96 and 1.35 percent, respectively; hazard ratio, 1.17). For most type-specific CVDs, increased risks were also seen, especially for myocardial infarction, ischemic heart disease, and heart failure. The association was seen regardless of whether the sibling died of CVD or non-CVD causes (hazard ratios, 2.54 and 1.13, respectively). Individuals who lost a twin or younger sibling had more a pronounced increased risk for CVD than those who lost an elder sibling (hazard ratios, 1.25 and 1.11, respectively).
"The findings highlight the need for extra attention and both social and mental support to bereaved siblings to reduce CVD risk later in life," the authors write.
One author disclosed ties to Novo Nordisk.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-01-09 04:15
Read more
- JAMA Oncology Publishes Phase 1b/2 Study Data on IASO Bio's Equecabtagene Autoleucel (Fucaso™) in the Treatment of Relapsed/Refractory Multiple Myeloma
- A Cancer Diagnosis Takes Devastating Toll on Family Finances
- Quitting Smoking After Cancer Diagnosis Boosts Survival by Up to 26%
- Nursing-Sensitive Quality Indicators Negatively Impacted by Pandemic
- FDA Approves Hympavzi for Hemophilia
- American College of Chest Physicians, Oct. 6-9
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions